标题
Cardiovascular effects of melatonin receptor agonists
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 11, Pages 1661-1678
出版商
Informa Healthcare
发表日期
2012-08-23
DOI
10.1517/13543784.2012.714771
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Melatonin and cardioprotection in the acute myocardial infarction: A promising cardioprotective agent
- (2012) Alberto Dominguez-Rodriguez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Melatonina y enfermedad cardiovascular: ¿mito o realidad?
- (2012) Alberto Dominguez-Rodriguez et al. REVISTA ESPANOLA DE CARDIOLOGIA
- A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression
- (2011) Robert H. Howland DRUG SAFETY
- Tasimelteon for insomnia
- (2011) D Alan Lankford EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Agomelatine for the treatment of major depressive disorder
- (2011) Regina M Carney et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia
- (2011) Masako Kohsaka et al. Expert Review of Neurotherapeutics
- Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm?
- (2011) Kazuomi Kario Journal of the American Society of Hypertension
- Melatonin and the Metabolic Syndrome: Physiopathologic and Therapeutical Implications
- (2011) Daniel P. Cardinali et al. NEUROENDOCRINOLOGY
- A review of ramelteon in the treatment of sleep disorders
- (2011) David Neubauer Neuropsychiatric Disease and Treatment
- Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
- (2010) Shao-wen Tian et al. ACTA PHARMACOLOGICA SINICA
- Usefulness of Intraplatelet Melatonin Levels to Predict Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
- (2010) Alberto Dominguez-Rodriguez et al. AMERICAN JOURNAL OF CARDIOLOGY
- Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats
- (2010) Gregory F. Oxenkrug et al. Annals of the New York Academy of Sciences
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
- (2010) Alan G Wade et al. BMC Medicine
- Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment
- (2010) Gilberto Spadoni et al. CNS Neuroscience & Therapeutics
- Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response
- (2010) Alan G. Wade et al. CURRENT MEDICAL RESEARCH AND OPINION
- Investigational melatonin receptor agonists
- (2010) Rüdiger Hardeland EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Urinary melatonin and risk of incident hypertension among young women
- (2010) John P Forman et al. JOURNAL OF HYPERTENSION
- Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment
- (2010) Ludovit Paulis et al. JOURNAL OF HYPERTENSION
- Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril
- (2010) Fedor Simko et al. JOURNAL OF HYPERTENSION
- MT2 Receptors Mediate the Inhibitory Effects of Melatonin on Nitric Oxide-Induced Relaxation of Porcine Isolated Coronary Arteries
- (2010) R. R. Tunstall et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats
- (2010) You-Lin Tain et al. JOURNAL OF PINEAL RESEARCH
- Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome
- (2010) Marzena Koziróg et al. JOURNAL OF PINEAL RESEARCH
- New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
- (2010) Ruediger Hardeland Neuropsychiatric Disease and Treatment
- Ramelteon: a review of its therapeutic potential in sleep disorders
- (2009) Seithikurippu R. Pandi-Perumal et al. ADVANCES IN THERAPY
- Melatonin: Signaling mechanisms of a pleiotropic agent
- (2009) Rüdiger Hardeland BIOFACTORS
- Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure
- (2009) Mustafa Yildiz et al. CARDIOLOGY IN THE YOUNG
- Agomelatine, a melatonin agonist with antidepressant properties
- (2009) Steven L Dubovsky et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats
- (2009) Miroslava Benova et al. HYPERTENSION RESEARCH
- Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability
- (2009) Tomasz Rechciński et al. HYPERTENSION RESEARCH
- Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action
- (2009) Venkataramanujan Srinivasan et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats
- (2009) Ludovit Paulis et al. JOURNAL OF HYPERTENSION
- Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats
- (2009) Fedor Simko et al. JOURNAL OF HYPERTENSION
- Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension
- (2009) Ludovit Paulis et al. JOURNAL OF PINEAL RESEARCH
- NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats
- (2009) Meihua She et al. PHARMACOLOGICAL RESEARCH
- Effects of circadian disruption on the cardiometabolic system
- (2009) Melanie Rüger et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action
- (2009) Siegfried Kasper et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Role of Melatonin in the Pathogenesis of Hypertension in Rats With Metabolic Syndrome
- (2008) A. Leibowitz et al. AMERICAN JOURNAL OF HYPERTENSION
- Agomelatine Treatment of Major Depressive Disorder
- (2008) Christian R Dolder et al. ANNALS OF PHARMACOTHERAPY
- Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites
- (2008) R. Hardeland CELLULAR AND MOLECULAR LIFE SCIENCES
- EFFECTS OF MELATONIN ON BLOOD PRESSURE IN STRESS-INDUCED HYPERTENSION IN RATS
- (2008) Chun-Mei Xia et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- MELATONIN REDUCES BLOOD PRESSURE IN RATS WITH STRESS-INDUCED HYPERTENSION VIA GABAARECEPTORS
- (2008) Hua-Li Li et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders
- (2008) Silvia Rivara et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Sleep dysfunction in heart failure
- (2008) Shahrokh Javaheri Current Treatment Options in Neurology
- Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials
- (2008) Shantha MW Rajaratnam et al. LANCET
- Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction
- (2007) Alberto Dominguez-Rodriguez et al. ATHEROSCLEROSIS
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started